<DOC>
	<DOCNO>NCT01906190</DOCNO>
	<brief_summary>This clinical study perform subject age 12-60 year old enrol NCT01310374 receive 2010 seasonal influenza vaccine evaluate persistence immune response influenza vaccine 24 month vaccination .</brief_summary>
	<brief_title>Persistence Immune Response After Vaccination With Influenza Vaccine</brief_title>
	<detailed_description>Subjects previously vaccinate 12 60 year age 2010 seasonal influenza vaccine.The persistence phase start 24 month primary vaccination blood sample take 6 , 12 , 18 24 month primary vaccination . Subjects whose antibody titer le 1:40 6 month primary vaccination receive booster dose influenza vaccine .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>age 1260 year old male nonpregnant female volunteer receive 2010 seasonal influenza vaccine clinically healthy determine : medical history inquire physical examination provide write informed consent join trial without history 2010 seasonal influenza vaccine administration , allergic ingredient vaccine , autoimmune disease immunodeficiency , severe adverse reaction vaccination , allergy , hive , breathe difficulty , angioedema abdominal pain , severe acute chronic disease axillary temperature 37.0â„ƒ time vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>immune response</keyword>
	<keyword>persistence</keyword>
</DOC>